The role of immunotherapy for the treatment mesothelioma



Published
Riyaz Shah, BSc(Hons), MBBS, FRCP, PhD, Kent Oncology Centre, UK, discusses the role of immunotherapy for the treatment of patient with mesothelioma. The Phase III CHECKMATE-743 (NCT02899299) study highlighting the benefit of immunotherapy in the first-line setting. This interview took place at the BTOG 2022 Summer Meeting congress in London.
Category
Health
Be the first to comment